Roche Holding AG
Roche Holding AG (RHHBY) Revenue
Annual & quarterly revenue history · segment & region breakdown
RHHBY · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsRoche Holding AG trailing twelve-month (TTM) revenue is $109B, an increase of 1.54% year-over-year from $63.36B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $63.36B | +$0.96B | +1.54% |
| 2024-12-31 | $62.40B | +$1.95B | +3.23% |
| 2023-12-31 | $60.44B | -$5.37B | -8.16% |
| 2022-12-31 | $65.81B | +$3.01B | +4.80% |
| 2021-12-31 | $62.80B | +$4.48B | +7.68% |
| 2020-12-31 | $58.32B | -$5.43B | -8.51% |
| 2019-12-31 | $63.75B | +$4.25B | +7.15% |
| 2018-12-31 | $59.50B | +$3.75B | +6.73% |
| 2017-12-31 | $55.75B | +$3.11B | +5.91% |
| 2016-12-31 | $52.64B | +$2.23B | +4.43% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare RHHBY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Roche Holding AG receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Roche Holding AG reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CHF.
Data sourced from Roche Holding AG's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
RHHBY revenue · 4 questionsRHHBY's trailing twelve-month (TTM) revenue is $109B. That is an increase of 1.54% year-over-year from $63.36B in FY2025.
▸ Source: FMP · Roche Holding AG SEC filings · GAAP · Roche Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026